Maintain Sample Integrity with New RNA Complete BCT™


New RNA Complete BCT™ is a direct draw blood collection tube, now available in the UK from Alpha Laboratories Ltd. These blood collection tubes contain a preservative that stabilises cell-free RNA and exosome counts, maintaining the draw time concentration for up to 7 days when stored at room temperature.

The specialised chemistry within RNA Complete BCT limits the degradation of white and red blood cells to maintain sample integrity during storage, shipping, and handling of blood samples. It reduces haemolysis, eliminates the need for immediate plasma preparation and increases plasma yield after storage. Compared to alternative blood collection tubes RNA Complete BCT offers a much more convenient workflow process.


By enabling room temperature storage of blood samples RNA Complete BCT reduces

costs and complications associated with cold chain shipping. Following pressure differential testing performed per IATA UN3373 standards, RNA Complete BCTs have been certified

fully 95kPa IATA compliant. This means they can be easily and conveniently transported using SpeciSafe® secondary packaging containers, to ensure full compliance with UN3373 regulations.


Please visit www.alphalabs.co.uk/bct for further information or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk  


Expanding Global IVD Business Exhibits at the World’s Largest Lab Expo

BBI Solutions (BBI), a leading and rapidly expanding manufacturer of raw materials and finished test...

Read More >

SpeeDx receives CE-IVD mark for multiplex PlexPCR® VHS test for VZV, herpes and syphilis

SYDNEY, AUSTRALIA–(October 25, 2017). SpeeDx Pty. Ltd. has announced that it has received CE-IVD ma...

Read More >

Oxford Cancer Biomarkers launches ToxNav to improve morbidity and mortality rates in patients undergoing CRC chemotherapy

Oxford Cancer Biomarkers Limited (www.oxfordbio.com) has announced the launch of ToxNav - a genomic ...

Read More >

European Reference Laboratory for Glycohemoglobin study reaffirms EKF’s Quo-Test® meets HbA1c performance criteria

Cardiff, UK – 16th February 2017 – EKF Diagnostics, the global in vitro diagnostics company, annou...

Read More >

Mologic receives a $4.8m grant to establish the centre for advanced rapid diagnostics ("card")

Mologic is pleased to announce that we are in receipt of a grant from the Bill & Melinda Gates Found...

Read More >